|Bid||16.08 x 0|
|Ask||16.20 x 0|
|Day's Range||13.77 - 14.66|
|52 Week Range||4.55 - 24.75|
|PE Ratio (TTM)||79.89|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||18.57|
Canada's main stock index was little changed on Friday as a boost from the heavyweight energy sector was offset by a decline in gold and natural resource companies, as well as cannabis producers. * At ...
The sale of legalized recreational marijuana in Canada, which has already been pushed back once beyond the planned July start date, is set to be delayed even further, government officials said on Thursday. The ruling Liberals are sparring with the upper Senate chamber, where a draft law is currently under review. Critics in the Senate - which must approve the law - complain the Liberals are moving too quickly.
Canopy Growth Corp, Canada's biggest marijuana producer, said on Wednesday its third-quarter revenue doubled and profit rose, even as analysts expected a loss. The earnings included a one-time gain of C$8.8 million from the sale of Canopy's Agripharm business. Excluding the one-time gain, the company had a loss of 2 Canadian cents, compared with expectations for a loss of 5 Canadian cents, according to Thomson Reuters I/B/E/S.
Aphria becomes one of the first suppliers of adult-use cannabis to La Belle Province LEAMINGTON, ON , Feb. 14, 2018 /CNW/ - Aphria Inc. (" Aphria " or the " Company ") ( TSX: APH and ...
Aphria signs letter of intent with SAQ to supply up to 12,000 kg of cannabis annually to Quebec market
TORONTO, Feb. 13, 2018-- Scythian Biosciences Corp. is pleased to announce that it has today closed its previously announced“ bought deal” short form prospectus offering, including the full exercise of ...
LEAMINGTON, ON, Feb. 13, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has closed the previously announced acquisition (the "Transaction") of Broken Coast Cannabis Inc. ("Broken Coast"), a leading premium cannabis producer located in British Columbia, acquiring 99.86% of all of the issued and outstanding Class A common shares. The closing was effected pursuant to the terms of a definitive share purchase agreement (the "SPA") dated the date hereof by and among the Company and the vendors party thereto (collectively, the "Vendors"). Pursuant to the SPA, the Company has acquired the Class A common shares held by the Vendors for an aggregate purchase price of approximately CAN$217 million, subject to customary adjustments.
Canadian regulators on Thursday reiterated their call for listed cannabis producers with U.S. businesses to clearly disclose risks of operating there, and warned of potential punishment if U.S. federal anti-marijuana laws are more strictly enforced. The CSA notice, similar to one it issued in October, stopped short of taking any action against listed marijuana producers with U.S. operations. This raised fears that Canadian companies with U.S. operations could be open to prosecution.
Aphria Inc (TSX:APH) is trading with a trailing P/E of 76.5x, which is higher than the industry average of 52.2x. While this makes APH appear like a stock to avoidRead More...
Recreational marijuana in Canada will only go on sale a few months after it is legalized later this year because the new retail system needs time to start working properly, Health Minister Ginette Petitpas Taylor said on Tuesday. The Liberal government says the new law must be in place by July 1 this year, which would make Canada the first Group of Seven country to adopt such a policy. Some of Canada's 10 provinces, which are responsible for actually selling marijuana, complain they do not have enough time.
LEAMINGTON, ON, Feb. 5, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH or USOTCQB: APHQF) today announced that it entered into a purchase and sale agreement to sell 26,716,025 shares representing all its shares in Liberty Health Sciences Inc.. ("Liberty") that are not subject to Canadian Securities Exchange ("CSE") escrow requirements (the "Transaction"). Each of Michael Serruya, Simon Serruya and Jack Serruya are purchasing 80% of all transferred shares from Aphria individually or through an affiliate.
LEAMINGTON, ON and TORONTO, Feb. 2, 2018 /CNW/ - Aphria Inc. (TSX: APH or OTCQB: APHQF) ("Aphria") and Liberty Health Sciences Inc. (CSE:LHS or OTCQB:LHSIF) ("Liberty") jointly announce that they have entered into a definitive agreement (the "Agreement") with respect to the sale (the "Transaction") of Aphria's subsidiary Aphria (Arizona) Inc. and its sole holdings being the minority membership interests in Copperstate Farms, LLC and Copperstate Farms Investors, LLC (collectively "Copperstate") to Liberty for a purchase price of $20 million ("Purchase Price"). "The sale of Copperstate is an important step in our continued efforts to work collaborately with the TSX and Canadian securities regulatory authorities regarding the divestiture of our direct investment in a US cannabis business," said Vic Neufeld, Chief Executive Officer of Aphria.
Aphria and Liberty Health Sciences Announce Definitive Agreement for Sale of Aphria's Investment in Copperstate Farms to Liberty
Canada's benchmark stock index ended its fourth day of losses at a 14-week low, as a hawkish Federal Reserve sapped demand for equities, with two cannabis producers posting the biggest declines on Thursday. ...
LEAMINGTON, ON, Feb. 1, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH or USOTCQB: APHQF) confirms today that the Company is currently exploring and considering strategic alternatives with respect to its US cannabis related interests, including the possible divestiture of its investments to strategic, long-term and committed investors in the cannabis industry. Aphria Inc., one of Canada's lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada. Aphria is truly powered by sunlight, allowing for the most natural growing conditions available. We are committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders. CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information in this news release constitutes forward-looking statements under applicable securities laws.
The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy. THE GLOBE AND MAIL ** The provinces outside Quebec are ...
Canada's main stock index fell on Monday, touching a six-week low as energy and other resource shares tumbled alongside commodity prices. * The Toronto Stock Exchange's S&P/TSX composite index ended down ...
Canada's main stock index fell on Monday, hitting its lowest level in a month as energy and other resource shares declined alongside the price of oil. * At 10:24 a.m. ET , the Toronto Stock Exchange's ...
Canadian cannabis company Aphria Inc said Monday it would buy rival Nuuvera Inc for C$826 million ($670 million), ahead of a raft of medical cannabis approvals around the world over the coming years. The transaction comes less than a week after another takeover created the world's biggest weed company by market value and as Canada, which has allowed medical marijuana since 2001, gears up to legalize recreational use by mid-2018. The deal would help Aphria expand its footprint to 11 countries including Germany, Italy and Israel, and its offer of about C$8.50 per share represents a 21 percent premium to Nuuvera's closing price on Friday.